Literature DB >> 18259981

IPCS framework for analyzing the relevance of a noncancer mode of action for humans.

Alan R Boobis1, John E Doe, Barbara Heinrich-Hirsch, M E Bette Meek, Sharon Munn, Mathuros Ruchirawat, Josef Schlatter, Jennifer Seed, Carolyn Vickers.   

Abstract

Structured frameworks are extremely useful in promoting transparent, harmonized approaches to the risk assessment of chemicals. One area where this has been particularly successful is in the analysis of modes of action (MOAs) for chemical carcinogens in experimental animals and their relevance to humans. The International Programme on Chemical Safety (IPCS) recently published an updated version of its MOA framework in animals to address human relevance (cancer human relevance framework, or HRF). This work has now been extended to noncancer effects, with the eventual objective of harmonizing framework approaches to both cancer and noncancer endpoints. As in the cancer HRF, the first step is to determine whether the weight of evidence based on experimental observations is sufficient to establish a hypothesized MOA. This comprises a series of key events causally related to the toxic effect, identified using an approach based on the Bradford Hill criteria. These events are then compared qualitatively and, next, quantitatively between experimental animals and humans. The output of the analysis is a clear statement of conclusions, together with the confidence, analysis, and implications of the findings. This framework provides a means of ensuring a transparent evaluation of the data, identification of key data gaps and of information that would be of value in the further risk assessment of the compound, such as on dose-response relationships, and recognition of potentially susceptible subgroups, for example, based on life-stage considerations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259981     DOI: 10.1080/10408440701749421

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  46 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  Adverse outcome pathway development II: best practices.

Authors:  Daniel L Villeneuve; Doug Crump; Natàlia Garcia-Reyero; Markus Hecker; Thomas H Hutchinson; Carlie A LaLone; Brigitte Landesmann; Teresa Lettieri; Sharon Munn; Malgorzata Nepelska; Mary Ann Ottinger; Lucia Vergauwen; Maurice Whelan
Journal:  Toxicol Sci       Date:  2014-12       Impact factor: 4.849

3.  Adverse outcome pathway (AOP) development I: strategies and principles.

Authors:  Daniel L Villeneuve; Doug Crump; Natàlia Garcia-Reyero; Markus Hecker; Thomas H Hutchinson; Carlie A LaLone; Brigitte Landesmann; Teresa Lettieri; Sharon Munn; Malgorzata Nepelska; Mary Ann Ottinger; Lucia Vergauwen; Maurice Whelan
Journal:  Toxicol Sci       Date:  2014-12       Impact factor: 4.849

4.  Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.

Authors:  Katherine K Coady; Ronald C Biever; Nancy D Denslow; Melanie Gross; Patrick D Guiney; Henrik Holbech; Natalie K Karouna-Renier; Ioanna Katsiadaki; Hank Krueger; Steven L Levine; Gerd Maack; Mike Williams; Jeffrey C Wolf; Gerald T Ankley
Journal:  Integr Environ Assess Manag       Date:  2017-01-18       Impact factor: 2.992

Review 5.  Case examples of an evaluation of the human relevance of the pyrethroids/pyrethrins-induced liver tumours in rodents based on the mode of action.

Authors:  Tomoya Yamada
Journal:  Toxicol Res (Camb)       Date:  2018-01-16       Impact factor: 3.524

6.  Screening for human urinary bladder carcinogens: two-year bioassay is unnecessary.

Authors:  Samuel M Cohen
Journal:  Toxicol Res (Camb)       Date:  2018-01-23       Impact factor: 3.524

Review 7.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

8.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.

Authors:  Richard Judson; Robert Kavlock; Matthew Martin; David Reif; Keith Houck; Thomas Knudsen; Ann Richard; Raymond R Tice; Maurice Whelan; Menghang Xia; Ruili Huang; Christopher Austin; George Daston; Thomas Hartung; John R Fowle; William Wooge; Weida Tong; David Dix
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

9.  The Key Events Dose-Response Framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds.

Authors:  Elizabeth Julien; Alan R Boobis; Stephen S Olin
Journal:  Crit Rev Food Sci Nutr       Date:  2009-09       Impact factor: 11.176

10.  Application of key events analysis to chemical carcinogens and noncarcinogens.

Authors:  Alan R Boobis; George P Daston; R Julian Preston; Stephen S Olin
Journal:  Crit Rev Food Sci Nutr       Date:  2009-09       Impact factor: 11.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.